Objective. As the expected survival improves for individuals with cyst
ic fibrosis, these individuals face myriad medical complications. The
goals of this study were to examine the prevalence of osteopenia in ch
ildren and adults with cystic fibrosis and to elucidate the risk facto
rs associated with deficits in bone mineral. Methodology. We compared
bone mineral levels in 49 patients (30 female and 19 male) ages 8 thro
ugh 48 years with those of age- and sex-matched control subjects. Lumb
ar spine, femoral neck, and whole-body bone mineral were measured by d
ual-energy radiographic absorptiometry and expressed in terms of bone
mineral content, areal bone density (BMD), and bone mineral apparent d
ensity (BMAD), which corrects for differences in bone size. Clinical v
ariables were evaluated as potential correlates of bone mineral. Resul
ts. Patients with cystic fibrosis had significantly less bone mineral
than did control subjects at all sites using all expressions of bone m
ass. Mean BMD z scores were -1.7 (lumbar spine), -1.9 (femoral neck),
and -1.2 (whole body). BMAD z scores also were significantly low for a
ge and gender. Twenty-six of the 49 patients (8 adolescents) had signi
ficant osteopenia according to their BMD z scores; 14 of the 45 patien
ts (5 adolescents) with available BMAD z scores had significantly low
values at one or more sites. Age, pubertal stage, body mass, caloric e
xpenditure, illness severity, glucocorticoid therapy, and gonadal func
tion predicted bone mineral status. Serum parathyroid hormone and calc
ium, carbohydrate intake, and weight-bearing activity had limited pred
ictive value. Daily calcium intake and cystic fibrosis transmembrane r
egulator genotype did not predict bone mineral status. Conclusions. Os
teopenia is common at all ages in cystic fibrosis, suggesting that ina
dequate bone mineral accretion as well as increased bone loss contribu
te to the deficits in bone mineral observed. Several clinical factors
seem to contribute to these deficits.